Nirogacestat
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Building a system to ensure awareness of nirogacestat, a treatment for desmoid tumors.
Journal: The American journal of managed care
Published: June 18, 2026
Systemic Therapies for Desmoid Tumors: A Review of Past, Present, and Future Treatments.
Journal: Cancers
Published: March 18, 2026
How have gamma-secretase inhibitors changed the treatment landscape for desmoid tumors?
Journal: Expert opinion on pharmacotherapy
Published: February 18, 2026
Regulatory Signaling Pathways in Ovarian Cancer Stem Cells: Their Role in Tumor Progression and Therapeutic Strategies.
Journal: Iranian biomedical journal
Published: January 28, 2026
Androgenic hidradenitis suppurativa onset linked to gamma secretase inhibitor.
Journal: JAAD case reports
Published: January 09, 2026
Are we managing desmoid tumors correctly in Spain? Results of the first national survey.
Journal: Cirugia espanola
Published: December 16, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 20, 2025
Case Report: Nirogacestat therapy induces rapid response in a patient with refractory, life-threatening desmoid tumor.
Journal: Frontiers in oncology
Published: September 27, 2025
Disproportionality analysis of dermatologic adverse events associated with nirogacestat: Insights from the U.S. Food and Drug Administration Adverse Event Reporting System.
Journal: Journal of the American Academy of Dermatology
Published: September 05, 2025
Repurposing nirogacestat, a gamma secretase enzyme inhibitor in desmoid tumors.
Journal: Future oncology (London, England)
Published: September 01, 2025
Last Updated: 06/30/2026